In our study, ICT treatment decreased the expression of IL-1β and TNF-α while increasing the level of IL-10, indicating that ICT inhibited neuroinflammation and cerebral edema induced by tMCAO in rats by decreasing proinflammatory cytokine levels and increasing anti-inflammatory cytokine levels. This evidence concerns the gene IL1B and brain edema.